search

Tenvir-EM

€70.17

The ingredients of Tenvir-EM (Truvada) are emtricitabine (200mg) and tenofovir disoproxil fumarate (300mg) PDT. These are the active ingredients used in HIV-negative people. This type of Tenvir EM regimen is known as PrEP (pre-exposure prophylaxis) and is almost entirely successful in preventing HIV infection.

As far as adverse effects of Tenvir EM are concerned, only a very small number of people have reported symptoms such as nausea, malaise, fever or skin rashes, which disappear immediately after stopping the PREP treatment. Pre-exposure prophylaxis treatment can be started and stopped in any situation and without the need for a pattern. For HIV-positive people, more specific medication is available and should be used instead of Tenvir or any other PrEP.

Quantity

Tenvir EM is equivalent to Ricovir EM

Tenofovir disoproxil 300mg and Emtricitabine 200mg (Truvada) is used as PrEP (pre-exposure prophylaxis) in HIV (human immunodeficiency virus) negative people. 

2
5/ 5
5 1
2020-07-01

Data sheet

Supply Length
30 days
Dosage
1 tablet in the morning
Expiry date
AGO.2022
Presentation
Film-coated Tablets
Trademark
Truvada
FDA Approvals
ANDA 090958 02/26/2014
Packaging Type
HDPE bottle
Storage
Store below 30°C
chat Comments (5)
Grade
No customer reviews for the moment.